Trial Profile
An open label, fixed sequence, 2 period study to investigate the drug drug interaction between elbasvir/grazoprevir with dolutegravir in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Aug 2015
Price :
$35
*
At a glance
- Drugs Dolutegravir (Primary) ; Elbasvir/grazoprevir (Primary)
- Indications Hepatitis C
- Focus Pharmacokinetics
- 28 Aug 2015 New trial record